Back to Search Start Over

Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.

Authors :
Child, Christopher J
Zimmermann, Alan G
Chrousos, George P
Cummings, Elisabeth
Deal, Cheri L
Hasegawa, Tomonobu
Jia, Nan
Lawrence, Sarah
Linglart, Agnès
Loche, Sandro
Maghnie, Mohamad
Pérez Sánchez, Jacobo
Polak, Michel
Predieri, Barbara
Richter-Unruh, Annette
Rosenfeld, Ron G
Yeste, Diego
Yorifuji, Tohru
Blum, Werner F
Source :
The Journal of Clinical Endocrinology & Metabolism; February 2019, Vol. 104 Issue: 2 p379-389, 11p
Publication Year :
2019

Abstract

Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy.

Details

Language :
English
ISSN :
0021972X and 19457197
Volume :
104
Issue :
2
Database :
Supplemental Index
Journal :
The Journal of Clinical Endocrinology & Metabolism
Publication Type :
Periodical
Accession number :
ejs51162532
Full Text :
https://doi.org/10.1210/jc.2018-01189